Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Lancet (London, England)
|
September 17, 1983
Impairment of recall improves tolerance of cytotoxic chemotherapy
M L Friedlander, K Sims, J H Kearsley
British Journal of Cancer
|
April 1, 1986
Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia
J R Zalcberg, M L Friedlander, M D Minden
Women & Health
|
January 1, 1984
Abortion: predicting the complexity of the decision-making process
M L Friedlander, T J Kaul, C A Stimel
Cytometry
|
July 1, 1985
Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance
D W Hedley, M L Friedlander, I W Taylor
Journal of Clinical Pathology
|
September 1, 1984
Clinical and biological significance of aneuploidy in human tumours
M L Friedlander, D W Hedley, I W Taylor
Australian and New Zealand Journal of Medicine
|
August 1, 1993
Chemotherapy made easier
C R Lewis, E Segelov, D Goldstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1988
Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer
M L Friedlander, D W Hedley, C Swanson, et al.
British Journal of Cancer
|
February 1, 1984
Cellular DNA content--a stable feature in epithelial ovarian cancer
M L Friedlander, I W Taylor, P Russell, et al.
Cancer Research
|
March 1, 1985
Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake
I W Taylor, P Slowiaczek, M L Friedlander, et al.
British Journal of Cancer
|
March 1, 1985
Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer
M L Friedlander, P Russell, I W Taylor, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Lancet (London, England)
|
September 17, 1983
Impairment of recall improves tolerance of cytotoxic chemotherapy
M L Friedlander, K Sims, J H Kearsley
British Journal of Cancer
|
April 1, 1986
Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia
J R Zalcberg, M L Friedlander, M D Minden
Women & Health
|
January 1, 1984
Abortion: predicting the complexity of the decision-making process
M L Friedlander, T J Kaul, C A Stimel
Cytometry
|
July 1, 1985
Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance
D W Hedley, M L Friedlander, I W Taylor
Journal of Clinical Pathology
|
September 1, 1984
Clinical and biological significance of aneuploidy in human tumours
M L Friedlander, D W Hedley, I W Taylor
Australian and New Zealand Journal of Medicine
|
August 1, 1993
Chemotherapy made easier
C R Lewis, E Segelov, D Goldstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1988
Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer
M L Friedlander, D W Hedley, C Swanson, et al.
British Journal of Cancer
|
February 1, 1984
Cellular DNA content--a stable feature in epithelial ovarian cancer
M L Friedlander, I W Taylor, P Russell, et al.
Cancer Research
|
March 1, 1985
Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake
I W Taylor, P Slowiaczek, M L Friedlander, et al.
British Journal of Cancer
|
March 1, 1985
Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer
M L Friedlander, P Russell, I W Taylor, et al.
Page
of 8